News

Professor Antti Poso’s research group is part of an effort seeking to find increasingly efficient and better targeted drugs for tuberculosis.

One third of hypertrophic cardiomyopathy cases in Finland are caused by one of the four major mutations, a new study from the University of Eastern Finland and Kuopio University Hospital shows.